AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

January 14, 2026

UCB’s Psoriasis Drug Application Faces a Further FDA Delay

September 21, 2023

Long-Term Data Shows Leqembi Slows Alzheimer’s Progression Over Four Years

August 2, 2025

Must Read

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

May 8, 2026

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

May 8, 2026

Is Green Biotech the Future of Sustainable Drug Development?

May 6, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Gedatolisib from Celcuity outperforms Piqray from Novartis in phase 3 research

Takeda Reports Phase 2/3 Data Showing TAK-881 Comparable to HyQvia in Primary Immunodeficiency Disease

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Amgen Adds $300 Million to Puerto Rico Expansion, Bringing U.S. Investment Commitments Near $2 Billion

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Teva Pens Deal Worth Over $700M to Buy Emalex

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Is Green Biotech the Future of Sustainable Drug Development?

Top 10 High-Impact Careers Defining the Future of Life Sciences

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Clinical

Medtronic Highlights Improved Results with Affera PFA Technology

Editor Picks

AbbVie Licenses Ex-China Rights to RemeGen’s PD-1/VEGF Bispecific RC148 for $650 Million Upfront

UCB’s Psoriasis Drug Application Faces a Further FDA Delay

Long-Term Data Shows Leqembi Slows Alzheimer’s Progression Over Four Years

Must Read

Viridian’s Tepezza Competitor Hits Another Phase 3 Win; Door Opens For FDA Nod

Myqorzo from Cytokinetics wins historic cardiomyopathy trial

Is Green Biotech the Future of Sustainable Drug Development?

Hot Topics

About Us

Follow Us